Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1979-07-31
1984-01-03
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
424128, 424224, 424258, 424263, 424326, 424336, 546300, 546162, A01N 3166, A01N 3115, A01N 3144, A01N 3147
Patent
active
044242166
ABSTRACT:
A method for reducing mucin viscosity which comprises administering an effective dose of a compound having protected sulfhydryl groups which metabolize in vivo to produce free sulfhydryl groups.
REFERENCES:
patent: 3892824 (1975-07-01), Piper et al.
"Studies on the Reduction of Sputum Viscosity in Cystic Fibrosis Using an Orally Absorbed Protected Thiol", Tabachnik, Peterson, and Cerami, Apr. 22, 1980; vol. 214, No. 2; pp. 246-249.
"Protein Binding of N-2-Mercaptoethyl-1,3-Diaminopropane via Mixed Disulfide Formation after Oral Administration of WR 2721.sup.1 ", Tabachnik, Blackburn, Peterson and Cerami; vol. 220, No. 2; Oct. 19, 1981; pp. 243-246.
"Biochemical and Rheological Characterization of Sputum Mucins from a Patient with Cystic Fibrosis", Tabachnik, Blackburn, and Cerami; vol. 256, No. 14; Jul. 25, 1981, pp. 7161-7165.
Survey of Compounds which have been Tested for Carcinogenic Activity, pp. 21,23,113,153,154,469; Thompson and Co., Publishers, DHEW Pub. No. (NIH)72-35 (1968-1969 volume).
Cerami Anthony
Tabachnik Nina F.
Rotman Alan L.
The Rockefeller University
LandOfFree
Method for the reduction of mucin viscosity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the reduction of mucin viscosity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the reduction of mucin viscosity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1031716